Diets in Oncology
Evidence-based dietary patterns relevant to cancer prevention and care — what research actually supports, without miracle claims. Diet supports treatment; it never replaces it.
Low-bacterial (neutropenic) diet
The low-bacterial (neutropenic) diet is a set of food restrictions - no raw vegetables or fruit, no mould-ripened cheese, no unpasteurised products - used for decades in patients with profound neutropenia after high-dose chemotherapy and haematopoietic stem cell transplantation. Randomised trials have not shown that it reduces infections, mortality or length of hospital stay, and a 2025 paediatric guideline recommends against such restrictions. A possible cost is signalled instead: restrictions worsen nutritional status and quality of life while further limiting an already low food intake. Abandoning the list of banned foods does not mean abandoning safe food-handling rules, which remain recommended.
Read more — evidence, cautions, sources
WHAT THIS DIET IS AND WHERE IT CAME FROM. The low-bacterial diet grew out of simple reasoning: if a patient after high-dose chemotherapy has very few granulocytes, cut off the bacteria that come with food. For decades it was standard practice on haematology and transplant wards. Typical restrictions include:
- raw vegetables and fruit, especially those that cannot be peeled,
- mould-ripened and soft ripened cheeses, unpasteurised products,
- raw or undercooked meat, fish and eggs,
- loose nuts, sprouts, unpasteurised honey.
WHAT THE EVIDENCE SHOWS
A 2025 systematic review covered 5 randomised trials and a total of 510 adults after high-dose therapy and haematopoietic stem cell transplantation; none of the analysed endpoints - infections, gastrointestinal complications, mortality, length of hospital stay - favoured the neutropenic diet [1].
A second 2025 systematic review, published together with a clinical practice guideline, pooled 8 randomised trials in children with cancer and haematopoietic cell transplant recipients. The data were consistent: food restrictions lack clinically significant benefit in preventing infections, and the panel issued a conditional recommendation AGAINST their use [2].
A single randomised trial in paediatric oncology illustrates this best: among 150 participants, infection during neutropenia occurred in 33% of those following food safety guidelines alone and in 35% of those additionally following the neutropenic diet - no statistically significant difference, while the restrictive arm reported a clearly greater adherence burden [5].
An earlier 2019 meta-analysis reached the same conclusion in adults: no statistically significant difference in major infections or in bacteraemia and fungaemia between the neutropenic and the regular diet, with a slightly HIGHER infection risk on the restrictive diet in the stem cell transplant subgroup. The authors conclude that there is no evidence to support the use of a neutropenic diet or other food restrictions in neutropenic patients with cancer, and refer instead to food-handling guidelines [4].
A 2023 systematic review (12 reports, 3,469 participants) adds the quality-of-life dimension: the low-bacterial diet did not reduce infection or mortality rates compared with a free diet, and was associated with poorer quality of life resulting from a limited and less palatable menu [6].
STRENGTH OF EVIDENCE
Moderate and consistent in direction. In its favour: the data come from randomised trials rather than observations, and several independent systematic reviews converge on the same conclusion [1][2][4][6]. Against full certainty: the individual trials are small, the definition of the low-bacterial diet varies between centres, and the paediatric guideline recommendation is CONDITIONAL rather than strong [2]. The honest summary is therefore: no benefit has been demonstrated - not "the diet has been proven harmful".
DOES LIBERALISING THE DIET HELP BY ITSELF
The honest answer is: on its own, not much. In a randomised trial in patients undergoing haematopoietic stem cell transplantation, a liberalised diet encouraging fresh fruit and vegetables did not improve energy intake during neutropenia (678 versus 724 kcal per day; p=0.46) or protein intake [3]. Lifting the restrictions is therefore not by itself a remedy for malnutrition - planned nutritional support is what is needed.
WHAT THESE RESULTS DO NOT SAY
They do not say that food hygiene no longer matters. Safe food-handling rules - thorough washing, avoiding raw meat, fish and eggs, respecting use-by dates, separate boards and utensils for raw produce, avoiding food of uncertain origin - remain recommended regardless of whether a list of banned products is used [4][7]. The difference concerns restrictive lists, not hygiene itself.
WHO THIS MATTERS FOR
Primarily patients with haematological malignancies treated with high-dose chemotherapy and stem cell transplantation, because that is the population studied [1][2]. For patients with solid tumours who become neutropenic after standard chemotherapy, evidence of this quality does not exist - which does not mean the neutropenic diet helps them, only that it has not been tested in them.
WHAT TO DISCUSS WITH THE TREATING TEAM
Centre practice varies and some units still apply restrictions. The scope of the diet during neutropenia is set by the treating team, which knows the patient's nutritional status and the ward's epidemiological situation.
Alcohol and cancer risk
Alcohol is classified by IARC as a Group 1 carcinogen — the same category as asbestos and tobacco smoke — and a causal link is established for cancers of the oral cavity and throat, larynx, oesophagus, liver, colorectum and breast. Risk rises with the amount consumed, but it does not begin only at heavy drinking: WHO states that half of alcohol-attributable cancers in the European Region arise from light and moderate consumption. No threshold of intake has been shown below which cancer risk is absent. Stopping drinking lowers the risk of several of these cancers, although returning to the level of never-drinkers takes years.
Read more — evidence, cautions, sources
WHY THIS ENTRY EXISTS AT ALL
Alcohol is rarely treated as a nutritional factor with oncological significance, yet it is one of the best documented. The International Agency for Research on Cancer (IARC) classifies it as a Group 1 carcinogen — the highest category, which also contains asbestos, ionising radiation and tobacco [2].
FOR WHICH CANCERS THE LINK IS CAUSAL
The NCI lists cancers of the oral cavity and throat, larynx, oesophagus (squamous cell form), liver, colorectum and breast [1]. Risk figures relative to non-drinkers, as given by the NCI [1]:
- oral cavity and throat: 1.1 times in light drinkers, 5 times in heavy drinkers;
- oesophagus (squamous cell): 1.3 times in light drinkers, 5 times in heavy drinkers;
- liver: 2 times in heavy drinkers;
- breast: 1.04 times in light, 1.23 times in moderate, 1.6 times in heavy drinkers;
- colorectum: 1.2 to 1.5 times in moderate to heavy drinkers.
IS THERE A SAFE DOSE
WHO answers plainly that there is not: "there is no safe amount that does not affect health", and the risk "starts from the first drop" [3]. This is not rhetoric — WHO states that half of alcohol-attributable cancers in the European Region arise from light and moderate consumption (less than 1.5 litres of wine, 3.5 litres of beer or 450 ml of spirits weekly), and that this very pattern accounts for the majority of alcohol-attributable breast cancers in women [3].
HOW ALCOHOL DAMAGES CELLS
The NCI points to several parallel mechanisms [1]: conversion of ethanol to acetaldehyde, a carcinogen that damages DNA; generation of reactive oxygen species and oxidative damage; impaired absorption of nutrients; increased absorption of other carcinogens (which explains the overlap between alcohol and tobacco); raised oestrogen levels; disrupted folate metabolism.
WHAT STOPPING ACHIEVES
The NCI states that discontinuing alcohol reduces the risk of cancers of the mouth, throat, oesophagus, breast and colorectum, while noting that "it may take years for the risks of cancer to return to those of never drinkers" — and adding that it is never too late to stop [1].
WHAT THESE DATA DO NOT SAY
They do not say that, in someone already under cancer treatment, stopping alcohol replaces any part of that treatment; the figures quoted concern the RISK OF DEVELOPING cancer, not the treatment of diagnosed disease. Nor do they establish how large the effect is in an individual — these are population-level risks, overlaid by tobacco use, family history and other factors. Decisions about management of cancer are made by the specialist physician.
Sources
- National Cancer Institute — Alcohol and Cancer Risk (Fact Sheet): cancer.gov ↗
- IARC Monographs on the Identification of Carcinogenic Hazards to Humans — Alcohol consumption, Group 1 (via WHO/Europe): who.int ↗
- World Health Organization, Regional Office for Europe — No level of alcohol consumption is safe for our health (2023): who.int ↗
Alkaline diet and alkaline water
A systematic review published in BMJ Open screened 8278 citations and found ONE study meeting the inclusion criteria — no randomised trials and no study evaluating alkaline diet or alkaline water for cancer treatment. Dietary changes shift urine pH but do not change blood pH, which the kidneys hold steady. The authors state plainly that promoting the alkaline diet and alkaline water for cancer prevention or treatment is not justified.
Read more — evidence, cautions, sources
WHY PEOPLE TURN TO IT
The alkaline diet and alkaline water are promoted by the media and by sellers as a way to "de-acidify the body" and thereby hinder cancer growth. The premise is that because cancer cells grow less well in an alkaline environment, the pH of the whole body can be shifted by what a person eats and drinks.
WHAT PHYSIOLOGY SAYS
A systematic review published in BMJ Open documented that dietary changes can alter URINE pH but do not change BLOOD pH. Dietary interventions moved urine pH by 0.2–1.2 units, while blood pH changed by only 0.01–0.02 units, because the kidneys excrete acid effectively and maintain systemic pH balance [1]. The premise on which the whole idea rests therefore fails at the level of physiology.
WHAT THE EVIDENCE SAYS
The same review identified 8278 citations and reviewed 252 abstracts. Exactly ONE study met the inclusion criteria [1].
- No randomised trials were located.
- No study was found that examined alkaline diet or alkaline water for cancer TREATMENT.
- The single included study found no association between dietary acid load and bladder cancer (OR 1.15; 95% CI 0.86–1.55; p = 0.36) [1].
WHAT THIS MEANS FOR THE READER
The authors write that despite promotion of the alkaline diet and alkaline water by the media and salespeople, there is almost no actual research to either support or disprove these ideas, and promoting them for cancer prevention or treatment is not justified [1]. "No high-quality evidence" is a complete and honest answer here — neither a promise nor silence replaces it.
It is also worth noting what is at stake beyond the water itself: restrictive versions of the alkaline diet limit protein and grain foods, and weight loss and malnutrition during cancer treatment are documented clinical problems [2]. Whether and how to modify eating during cancer is decided by the treating physician together with a clinical dietitian.
Sources
- [1] Fenton TR, Huang T. Systematic review of the association between dietary acid load, alkaline water and cancer. BMJ Open 2016;6:e010438: pmc.ncbi.nlm.nih.gov ↗
- [2] NCI PDQ — Nutrition in Cancer Care (Health Professional Version): cancer.gov ↗
This page is educational — it is not medical advice and does not replace consultation with an oncologist. Diagnostic and treatment decisions are made solely by specialist physicians.